santen Archives -

Verily is planning a digital ophthalmology joint venture with Japan’s specialist in the field, Santen. The joint venture

Verily plans digital ophthalmology joint venture with Santen

https://pharmaphorum.com/news/verily-plans-ophthalmology-joint-venture-with-santen/

UK biotech Oxford Biomedica and Japan’s Santen have begun an option and licence agreement to research and develop

Oxford Biomedica signs ophthalmology R&D deal with Santen

https://pharmaphorum.com/news/oxford-biomedica-signs-ophthalmology-rd-deal-with-santen/

Ophthalmic Drugs Conference London

Queen’s University Belfast and Santen to Present Opening Keynote this November

https://pharmaphorum.com/partner-content/queens-university-belfast-and-santen-to-present-opening-keynote-this-november/

Ophthalmic Drugs

The future of ocular gene editing is here

https://pharmaphorum.com/partner-content/the-future-of-ocular-gene-editing-is-here/

Ophthalmic Drugs Conference

Ophthalmic Drugs – Europe’s Leading Ophthalmic Conference

https://pharmaphorum.com/events/ophthalmic-drugs-europes-leading-ophthalmic-conference/

SMi’s Leading Ophthalmic Conference

Boehringer Ingelheim, Novaliq, Santen, Shire, at Europe’s Leading Ophthalmic Conference

https://pharmaphorum.com/partner-content/boehringer-ingelheim-novaliq-santen-shire-at-europes-leading-ophthalmic-conference/

5 Key Reasons Why You Should Attend

5 Key Reasons Why You Should Attend Europe’s Leading Ophthalmic Conference

https://pharmaphorum.com/partner-content/5-key-reasons-why-you-should-attend-europes-leading-ophthalmic-conference/

santen